Modeling of innate immune responses of cells for vaccine production

Chemical Engineering Science

Volumn 66, Issue 17, 2011, Pages 3954-3961

  Diaz Ochoa, J G ^a   Voigt, A ^a   Briesen, H ^c   Sundmacher, K ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biotechnology modeling; Cell heterogeneity; Cell population; Immune response; Monte Carlo simulations; Virus replication

Indexed keywords

CELL DYNAMICS; CELL POPULATION; CELL POPULATIONS; DYNAMICAL EVOLUTION; EXPERIMENTAL DATA; EXTENDED MODEL; HIGH YIELD; IMMUNE RESPONSE; IN-VITRO; INFLUENZA A VIRUS; INITIAL CONDITIONS; INNATE IMMUNE RESPONSE; KINETIC MONTE CARLO SIMULATION; MODEL APPROACH; MONTE CARLO SIMULATION; POPULATION BALANCE MODELS; REACTION CONSTANT; TIME LAG; VACCINE PRODUCTION; VIRUS ATTACKS; VIRUS REPLICATION;

ANTIBIOTICS; BIOCONVERSION; BIOREACTORS; CELL CULTURE; CELL PROLIFERATION; CELLS; GLYCOPROTEINS; IMMUNOLOGY; MONTE CARLO METHODS; POPULATION STATISTICS; VIRUSES;

COMPUTER SIMULATION;

EID: 79959675040     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2011.05.030     Document Type: Article

References (23)

1. Baccam P., Beauchemin C., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenza A virus infection in humans. J. Virol. 2006, 80:7590.
2. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signaling. Nat. Rev. Immunol. 2008, 8:911.
3. Diaz Ochoa, J.G., Voigt, A., Briesen, H., Sundmacher, K., 2009. Time dependent virus replication in cell cultures. In: Zhu, J. (Ed.), Complex 2009, Part I, LNICST, vol. 4, pp. 651-656.
4. Flint S.J., Enquist L.W., Racaniello V.R. Principles of Virology 2003, ASM Press. second ed.
5. Francoeur A.M., Lam T., Stanners C.P. PIF, a highly sensitive plaque assay for the introduction of interferon. Virology 1980, 105:525-535.
6. Genzel Y., Olmer R.M., Schafer B., Reichl U. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum-containing and serum-free media. Vaccine 2006, 24:6074.
7. Hadházy Gy., Strander H., Cantell K. Serum requirement for interferon production by suspended human leucocytes: studies on action of serum. J. Gen. Virol. 1969, 5:351.
8. Haseltine E.L., Lam V., Yin J., Rawlings J.B. Image-guided modeling of virus growth and spread. Bull. Math. Biol. 2008, 70:1730.
9. Haller O., Kochs G., Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344:119.
10. Howat T.J., Barreca C., O'Hare P., Gog J.R., Grenfell B.T. Modeling dynamics of type I interferon response in vitro viral infection. J. R. Soc. Interface 2006, 3:699.
11. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. B 1957, 147:258-273.
12. Lam V., Duca K.A., Yin J. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity. Biotechnol. Bioeng. 2005, 90:793-804.
13. Ludwig S., Planz O. Influenza viruses and the NF-κ B signaling pathway-towards a novel concept of antiviral therapy. Biol. Chem. 2008, 389:1307.
14. Medzhitov R., Janeway C.A. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 1997, 9:4.
15. Möhler L., Flockerzi D., Sann H., Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol. Bioeng. 2005, 90:46.
16. Müller, T., Schulze-Horsel, J., Sidorenko, Y., Reichl, U., & Kienle, A. (2008). Population balance modeling of influenza virus replication in MDCK cells during vaccine production. In 18th European Symposium on Computer Aided Process Engineering (p. 133). Amsterdam [u.a.]: Elsevier (ISBN 0-444-53227-7).
17. Sedmak J.J., Grossberg S.E. Interferon bioassay: reduction in yield of myxovirus neuramidases. J. Gen. Virol. 1973, 21:1.
18. Seitz C., Frensing T., Höpner D., Kochs G., Reichl U. High yields of influenza A virus in Madin-Darby canine kidney are promoted by insufficient interferon-induced antiviral state. J. Gen. Virol. 2010, 91:1.
19. Schulze-Horsel J., Genzel Y., Reichl U. Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production. BMC Biotechnol. 2008, 8:45.
20. Schulze-Horsel J., Schulze M., Agaladiris G., Genzel Y., Reichl U. Infection dynamics and virus induced apoptosis in cell-culture based influenza vaccine production-flow cytometry and mathematical modeling. Vaccine 2009, 27:2712.
21. Sidorenko Y., Schulze-Horsel J., Voigt A., Reichl U., Kienle A. Stochastic population balance modeling of influenza virus replication in vaccine production processes. Chem. Eng. Sci. 2008, 63:157.
22. Takaoka A., Yanai H. Interferon signaling network in innate defense. Cell. Microbiol. 2006, 8:907-922.
23. Takeuschi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009, 227:75-86.